Published in J Paediatr Child Health on September 04, 2007
Integrating common and rare genetic variation in diverse human populations. Nature (2010) 32.30
Origins and functional impact of copy number variation in the human genome. Nature (2009) 23.63
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature (2010) 12.27
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet (2009) 4.32
ABC-SysBio--approximate Bayesian computation in Python with GPU support. Bioinformatics (2010) 1.76
Association between physical activity and risk of bleeding in children with hemophilia. JAMA (2012) 1.66
Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet (2012) 1.60
Genetic counsellors: a registration system to assure competence in practice in the United kingdom. Community Genet (2003) 1.56
Acute idiopathic portal vein thrombosis in a child: a case report and literature review. Thromb Res (2006) 1.48
Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost (2006) 1.44
Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek Plus and Thrombotest methods with venous international normalised ratio. Thromb Haemost (2004) 1.44
IVIG - is it the answer? Maternal administration of immunoglobulin for severe fetal red blood cell alloimmunisation during pregnancy: a case series. Aust N Z J Obstet Gynaecol (2009) 1.38
Founder population-specific HapMap panel increases power in GWA studies through improved imputation accuracy and CNV tagging. Genome Res (2010) 1.32
How does CT image noise affect 3D deformable image registration for image-guided radiotherapy planning? Med Phys (2008) 1.17
GPU accelerated biochemical network simulation. Bioinformatics (2011) 1.15
Anticoagulation clinics for children achieve improved warfarin management. Thromb Res (2004) 1.11
Sensitive and specific measurement of minimal residual disease in acute lymphoblastic leukemia. J Mol Diagn (2009) 1.03
Computational design approaches and tools for synthetic biology. Integr Biol (Camb) (2011) 0.99
Building the genetic counsellor profession in the United Kingdom: two decades of growth and development. J Genet Couns (2013) 0.95
Dosing and monitoring of enoxaparin (Low molecular weight heparin) therapy in children. Br J Haematol (2010) 0.95
Hemostasis in neonates and children: pitfalls and dilemmas. Blood Rev (2010) 0.94
Safety and efficacy of warfarin in paediatric patients with prosthetic cardiac valves: a retrospective audit. Thromb Res (2011) 0.93
Warfarin therapy in children who require long-term total parenteral nutrition. Pediatrics (2003) 0.92
Match performance and physical capacity of players in the top three competitive standards of English professional soccer. Hum Mov Sci (2013) 0.90
The leaf-area shrinkage effect can bias paleoclimate and ecology research. Am J Bot (2012) 0.90
Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial. Pediatr Blood Cancer (2014) 0.89
Heparin in the long-term management of ligneous conjunctivitis: a case report and review of literature. Blood Coagul Fibrinolysis (2011) 0.89
Bleeding disorders in teenagers presenting with menorrhagia. Aust N Z J Obstet Gynaecol (2005) 0.88
Reduced bone density in children on long-term warfarin. Pediatr Res (2005) 0.88
A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry. Aust N Z J Obstet Gynaecol (2011) 0.87
Off-label use of recombinant factor VIIa in pediatric patients. Pediatrics (2012) 0.87
Venous thromboembolic disease: a single-centre case series study. J Paediatr Child Health (2006) 0.86
Anticoagulation in neonates and children: Pitfalls and dilemmas. Blood Rev (2010) 0.85
Age-related differences in heparin response. Thromb Res (2005) 0.85
Change in serum procalcitonin (deltaPCT) predicts the clinical outcome of children admitted with febrile neutropenia. Br J Haematol (2002) 0.85
Executive function following child stroke: the impact of lesion location. J Child Neurol (2010) 0.82
The prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian antenatal population. Aust N Z J Obstet Gynaecol (2008) 0.82
Clinical outcomes of management of CVAD occlusions. Arch Dis Child (2011) 0.81
A clinical audit of antithrombin concentrate use in a tertiary paediatric centre. J Paediatr Child Health (2012) 0.81
Immune thrombocytopenia following successful treatment of cancer in children. Pediatr Blood Cancer (2006) 0.80
Executive function following child stroke: the impact of lesion size. Dev Neuropsychol (2011) 0.80
Genetics and blood--haemoglobinopathies and clotting disorders. Aust Fam Physician (2007) 0.80
Neonatal exchange transfusions in the 21st century: a single hospital study. J Paediatr Child Health (2013) 0.80
From EHRs to Linked Data: representing and mining encounter data for clinical expertise evaluation. AMIA Jt Summits Transl Sci Proc (2013) 0.80
Infant deaths due to heparin overdose: time for a concerted action on prevention. J Paediatr Child Health (2011) 0.80
The in vitro response to low-molecular-weight heparin is not age-dependent in children. Thromb Haemost (2010) 0.79
Hospitalisations for sickle-cell disease in an Australian paediatric population. J Paediatr Child Health (2012) 0.79
Quality of life assessment in children commencing home INR self-testing. Thromb Res (2013) 0.78
Myeloid sarcoma presenting as an isolated nodule in a patient with acute myelogenous leukemia. J Drugs Dermatol (2007) 0.78
Methemoglobin reductase deficiency: novel mutation is associated with a disease phenotype of intermediate severity. J Pediatr Hematol Oncol (2012) 0.78
Evaluation of a post-operative thrombin inhibitor replacement protocol to reduce haemorrhagic and thrombotic complications after paediatric liver transplantation. Thromb Res (2010) 0.78
Thromboembolic complications related to indwelling central venous catheters in children with oncological/haematological diseases: a retrospective study of 362 catheters. Support Care Cancer (2002) 0.78
Hemostatic response in paediatric patients undergoing cardiopulmonary bypass surgery. Pediatr Cardiol (2011) 0.78
Assessing the outcome of systemic tissue plasminogen activator for the management of venous and arterial thrombosis in pediatrics. J Pediatr Hematol Oncol (2007) 0.77
The quantitative and qualitative responses of platelets in pediatric patients undergoing cardiopulmonary bypass surgery. Pediatr Cardiol (2011) 0.77
HEEADSSS assessment for adolescents requiring anticoagulation therapy. Arch Dis Child (2011) 0.77
The economic costs of routine INR monitoring in infants and children--examining point-of-care devices used within the home setting compared to traditional anticoagulation clinic monitoring. Thromb Res (2013) 0.77
How competent are they? Graduate nurses self-assessment of competence at the start of their careers. Collegian (2014) 0.76
Cytotoxicity and physicochemical properties of hafnium oxide nanoparticles. Chemosphere (2011) 0.76
Thrombophilia interpretation in childhood stroke: a cautionary tale. J Child Neurol (2004) 0.76
Thrombophilia and cerebral vein thrombosis. Front Neurol Neurosci (2008) 0.76
Perinatal management of patients at high risk of homozygous protein C deficiency. Thromb Haemost (2002) 0.76
Assessing outcome measures of oral anticoagulation management in children. Thromb Res (2011) 0.76
Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95). Thromb Haemost (2009) 0.76
Applying decision tree induction for identification of important attributes in one-versus-one player interactions: a hockey exemplar. J Sports Sci (2013) 0.76
Management of warfarin in children with heart disease. Pediatr Cardiol (2011) 0.75
Temporal aspects of anti-heparin-PF4 antibodies in heparin-induced thrombocytopenia. Ann Thorac Surg (2006) 0.75
Estimation of transient increases in bleeding risk associated with physical activity in children with haemophilia. BMC Blood Disord (2008) 0.75
Letter to the Editor regarding "Routine coagulation tests in newborn and infants". J Thromb Thrombolysis (2007) 0.75
Preceptorship model positive. Aust Nurs J (2012) 0.75
Impact of climatic and soil conditions on environmental fate of atrazine used under plantation forestry in Australia. J Environ Manage (2010) 0.75
Prospective audit of patients with haemophilia: bleeding episodes and management. J Paediatr Child Health (2011) 0.75
Vacuolated lymphocytes–a diagnostic clue. Eur J Haematol (2010) 0.75
Compliance of antithrombotic management at a tertiary paediatric hospital with international guidelines: a 100-Day audit. Thromb Res (2011) 0.75
Development of a food sensation and genotyping informatics system for the University of Florida Center for Smell and Taste (UFCST). AMIA Annu Symp Proc (2008) 0.75
Anticoagulation in children. Thromb Res (2012) 0.75
Paediatric stroke: the need for interdisciplinary models of care. J Paediatr Child Health (2009) 0.75
Employing a clinical governance framework to engage nurses in research. J Nurs Care Qual (2012) 0.75
Plasmin generation and fibrinolysis in pediatric patients undergoing cardiopulmonary bypass surgery. Pediatr Cardiol (2011) 0.75
Safety and Efficacy Outcomes of Home and Hospital Warfarin Management Within a Pediatric Anticoagulation Clinic. J Pediatr Hematol Oncol (2016) 0.75
The experience of parents and children where children have been supported with a ventricular assist device as a bridge to heart transplantation. Pediatr Cardiol (2011) 0.75
An adolescent patient with post-thrombotic syndrome achieves excellence in sport. J Paediatr Child Health (2012) 0.75